NorthWest Biotherapeutics Inc (NWBO)

[meirluc]

Hankmanhub, read post 292157 which is my answer to Survivor.

My estimate is that 15 SOC and 78 Treatment patients became post 36(+) months survivors. That is a ratio of 5.2:1 in favor of the Treatment arm and far better than the 2.34:1 Treatment:SOC randomization outcome; this is my worse case scenario.

Survivor most probably referred to the fact that my estimate if correct would show the Treatment arm to have approximately a 2:1 post 36 months survival superiority over the SOC arm (5.2/2.34=2.2).